ClinicalTrials.Veeva

Menu

Detection of Helicobacter Pylori in Ulcerative Colitis Patients

T

Tanta University

Status

Unknown

Conditions

Inflammatory Bowel Diseases

Treatments

Diagnostic Test: Colonoscopy and biopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT03172000
IBD Helicobacter

Details and patient eligibility

About

Helicobacter pylori (H. pylori) infection is one of the most common infectious diseases in humans.

Full description

Several bacterial and viral agents may have a role in the aetiology of IBD. In theory, H. pylori infection could be involved in IBD by inducing alterations in gastric and/or intestinal permeability or by causing immunological derangements resulting in absorption of antigenic material and autoimmunity via various immunological pathways.

Enrollment

60 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • newly diagnosed ulcerative colitis

Exclusion criteria

  • Other diagnosis

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Colonoscopy and biopsy
Active Comparator group
Description:
IBD patients
Treatment:
Diagnostic Test: Colonoscopy and biopsy
Colonoscopic biopsy
No Intervention group
Description:
Non IBD patients colonoscopic biopsy

Trial contacts and locations

1

Loading...

Central trial contact

Sherief Abd-Elsalam, MD; sherief Abd-Elsalam, Consultant

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems